You are on page 1of 1

22 OCT

CHEM VS. COVID TIMELINE


2020 FDA approves first COVID-19 antiviral

Nucleoside analogues Other treatment candidates

Nucleoside analogues, molecules which The WHO have said there is insufficient
resemble naturally-occuring building evidence that remdesivir is effective against
blocks that make up virus RNA, have been SARS-CoV-2, and cautioned against its
developed for COVID-19. They’re picked up use. But another nucleoside analogue,
by the virus enzyme which copies RNA, RNA molnupiravir, does reduce the risk of
polymerase, but stop it from functioning, hospitalisation and death from COVID-19.
stopping the virus copying itself.
Molnupiravir (active form) N
Adenosine triphosphate NH2 OH
One of four nucleosides that triphosphate O N NH
N
make up RNA N
O
triphosphate O N HO OH
N
Remdesivir became the first antiviral drug to H
N
be approved in the USA for the treatment of OH
HO OH COVID-19. It is not as effective as first thought
triphosphate O N N
NH2 but similar drugs are in development.
Remdesivir (active form) O
N
HO OH
triphosphate N
O N Molnupiravir exists as two interchangeable structures.
One form mimics the uridine (U) nucleoside, the other
form mimics the cytidine (C) nucleoside.
N
HO OH Protease inhibitor drugs have also shown
promise. These drugs bind to the viral
The structural changes in nucleoside protease enzyme and stop the virus from
analogues are responsible for sabotaging copying itself. Pfizer’s PF-07321332 is an
the virus’s RNA replication process. example which is currently in clinical trials.
How did it help?
More effective medicines Combination therapy Future viruses
Understanding how antivirals Giving antiviral drugs in Some of the drugs being developed
against SARS-CoV-2 work, even if combination rather than against SARS-CoV-2 may also be
they are not particularly effective, individually is more effective at efffective against other viruses,
helps scientists work out how to blocking virus replication, so the making them potentially useful
make more effective drugs. more options we have the better. during future pandemics.

© Andy Brunning/Compound Interest 2021 - www.compoundchem.com


Ci Creative Commons Attribution-NonCommercial-NoDerivatives licence BY NC ND

You might also like